Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prescription Migraine Medication Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Sumatriptan
1.2.3 Rizatriptan
1.2.4 Others
1.3 Market by Application
1.3.1 Global Prescription Migraine Medication Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drug Store
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prescription Migraine Medication Market Perspective (2018-2029)
2.2 Prescription Migraine Medication Growth Trends by Region
2.2.1 Global Prescription Migraine Medication Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Prescription Migraine Medication Historic Market Size by Region (2018-2024)
2.2.3 Prescription Migraine Medication Forecasted Market Size by Region (2024-2029)
2.3 Prescription Migraine Medication Market Dynamics
2.3.1 Prescription Migraine Medication Industry Trends
2.3.2 Prescription Migraine Medication Market Drivers
2.3.3 Prescription Migraine Medication Market Challenges
2.3.4 Prescription Migraine Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prescription Migraine Medication Players by Revenue
3.1.1 Global Top Prescription Migraine Medication Players by Revenue (2018-2024)
3.1.2 Global Prescription Migraine Medication Revenue Market Share by Players (2018-2024)
3.2 Global Prescription Migraine Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prescription Migraine Medication Revenue
3.4 Global Prescription Migraine Medication Market Concentration Ratio
3.4.1 Global Prescription Migraine Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prescription Migraine Medication Revenue in 2022
3.5 Prescription Migraine Medication Key Players Head office and Area Served
3.6 Key Players Prescription Migraine Medication Product Solution and Service
3.7 Date of Enter into Prescription Migraine Medication Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prescription Migraine Medication Breakdown Data by Type
4.1 Global Prescription Migraine Medication Historic Market Size by Type (2018-2024)
4.2 Global Prescription Migraine Medication Forecasted Market Size by Type (2024-2029)
5 Prescription Migraine Medication Breakdown Data by Application
5.1 Global Prescription Migraine Medication Historic Market Size by Application (2018-2024)
5.2 Global Prescription Migraine Medication Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Prescription Migraine Medication Market Size (2018-2029)
6.2 North America Prescription Migraine Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Prescription Migraine Medication Market Size by Country (2018-2024)
6.4 North America Prescription Migraine Medication Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prescription Migraine Medication Market Size (2018-2029)
7.2 Europe Prescription Migraine Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Prescription Migraine Medication Market Size by Country (2018-2024)
7.4 Europe Prescription Migraine Medication Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prescription Migraine Medication Market Size (2018-2029)
8.2 Asia-Pacific Prescription Migraine Medication Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Prescription Migraine Medication Market Size by Region (2018-2024)
8.4 Asia-Pacific Prescription Migraine Medication Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prescription Migraine Medication Market Size (2018-2029)
9.2 Latin America Prescription Migraine Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Prescription Migraine Medication Market Size by Country (2018-2024)
9.4 Latin America Prescription Migraine Medication Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prescription Migraine Medication Market Size (2018-2029)
10.2 Middle East & Africa Prescription Migraine Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Prescription Migraine Medication Market Size by Country (2018-2024)
10.4 Middle East & Africa Prescription Migraine Medication Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Prescription Migraine Medication Introduction
11.1.4 GSK Revenue in Prescription Migraine Medication Business (2018-2024)
11.1.5 GSK Recent Development
11.2 Teva
11.2.1 Teva Company Detail
11.2.2 Teva Business Overview
11.2.3 Teva Prescription Migraine Medication Introduction
11.2.4 Teva Revenue in Prescription Migraine Medication Business (2018-2024)
11.2.5 Teva Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Prescription Migraine Medication Introduction
11.3.4 Pfizer Revenue in Prescription Migraine Medication Business (2018-2024)
11.3.5 Pfizer Recent Development
11.4 Amgen
11.4.1 Amgen Company Detail
11.4.2 Amgen Business Overview
11.4.3 Amgen Prescription Migraine Medication Introduction
11.4.4 Amgen Revenue in Prescription Migraine Medication Business (2018-2024)
11.4.5 Amgen Recent Development
11.5 Viatris
11.5.1 Viatris Company Detail
11.5.2 Viatris Business Overview
11.5.3 Viatris Prescription Migraine Medication Introduction
11.5.4 Viatris Revenue in Prescription Migraine Medication Business (2018-2024)
11.5.5 Viatris Recent Development
11.6 Allergan
11.6.1 Allergan Company Detail
11.6.2 Allergan Business Overview
11.6.3 Allergan Prescription Migraine Medication Introduction
11.6.4 Allergan Revenue in Prescription Migraine Medication Business (2018-2024)
11.6.5 Allergan Recent Development
11.7 Grunenthal
11.7.1 Grunenthal Company Detail
11.7.2 Grunenthal Business Overview
11.7.3 Grunenthal Prescription Migraine Medication Introduction
11.7.4 Grunenthal Revenue in Prescription Migraine Medication Business (2018-2024)
11.7.5 Grunenthal Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Detail
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Prescription Migraine Medication Introduction
11.8.4 Eli Lilly Revenue in Prescription Migraine Medication Business (2018-2024)
11.8.5 Eli Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Prescription Migraine Medication Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Sumatriptan
Table 3. Key Players of Rizatriptan
Table 4. Key Players of Others
Table 5. Global Prescription Migraine Medication Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Prescription Migraine Medication Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Prescription Migraine Medication Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Prescription Migraine Medication Market Share by Region (2018-2024)
Table 9. Global Prescription Migraine Medication Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Prescription Migraine Medication Market Share by Region (2024-2029)
Table 11. Prescription Migraine Medication Market Trends
Table 12. Prescription Migraine Medication Market Drivers
Table 13. Prescription Migraine Medication Market Challenges
Table 14. Prescription Migraine Medication Market Restraints
Table 15. Global Prescription Migraine Medication Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Prescription Migraine Medication Market Share by Players (2018-2024)
Table 17. Global Top Prescription Migraine Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Migraine Medication as of 2022)
Table 18. Ranking of Global Top Prescription Migraine Medication Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Prescription Migraine Medication Revenue (CR5 and HHI) & (2018-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Prescription Migraine Medication Product Solution and Service
Table 22. Date of Enter into Prescription Migraine Medication Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Prescription Migraine Medication Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Prescription Migraine Medication Revenue Market Share by Type (2018-2024)
Table 26. Global Prescription Migraine Medication Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Prescription Migraine Medication Revenue Market Share by Type (2024-2029)
Table 28. Global Prescription Migraine Medication Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Prescription Migraine Medication Revenue Market Share by Application (2018-2024)
Table 30. Global Prescription Migraine Medication Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Prescription Migraine Medication Revenue Market Share by Application (2024-2029)
Table 32. North America Prescription Migraine Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Prescription Migraine Medication Market Size by Country (2018-2024) & (US$ Million)
Table 34. North America Prescription Migraine Medication Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Prescription Migraine Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Prescription Migraine Medication Market Size by Country (2018-2024) & (US$ Million)
Table 37. Europe Prescription Migraine Medication Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Prescription Migraine Medication Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Prescription Migraine Medication Market Size by Region (2018-2024) & (US$ Million)
Table 40. Asia-Pacific Prescription Migraine Medication Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Prescription Migraine Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Prescription Migraine Medication Market Size by Country (2018-2024) & (US$ Million)
Table 43. Latin America Prescription Migraine Medication Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Prescription Migraine Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Prescription Migraine Medication Market Size by Country (2018-2024) & (US$ Million)
Table 46. Middle East & Africa Prescription Migraine Medication Market Size by Country (2024-2029) & (US$ Million)
Table 47. GSK Company Detail
Table 48. GSK Business Overview
Table 49. GSK Prescription Migraine Medication Product
Table 50. GSK Revenue in Prescription Migraine Medication Business (2018-2024) & (US$ Million)
Table 51. GSK Recent Development
Table 52. Teva Company Detail
Table 53. Teva Business Overview
Table 54. Teva Prescription Migraine Medication Product
Table 55. Teva Revenue in Prescription Migraine Medication Business (2018-2024) & (US$ Million)
Table 56. Teva Recent Development
Table 57. Pfizer Company Detail
Table 58. Pfizer Business Overview
Table 59. Pfizer Prescription Migraine Medication Product
Table 60. Pfizer Revenue in Prescription Migraine Medication Business (2018-2024) & (US$ Million)
Table 61. Pfizer Recent Development
Table 62. Amgen Company Detail
Table 63. Amgen Business Overview
Table 64. Amgen Prescription Migraine Medication Product
Table 65. Amgen Revenue in Prescription Migraine Medication Business (2018-2024) & (US$ Million)
Table 66. Amgen Recent Development
Table 67. Viatris Company Detail
Table 68. Viatris Business Overview
Table 69. Viatris Prescription Migraine Medication Product
Table 70. Viatris Revenue in Prescription Migraine Medication Business (2018-2024) & (US$ Million)
Table 71. Viatris Recent Development
Table 72. Allergan Company Detail
Table 73. Allergan Business Overview
Table 74. Allergan Prescription Migraine Medication Product
Table 75. Allergan Revenue in Prescription Migraine Medication Business (2018-2024) & (US$ Million)
Table 76. Allergan Recent Development
Table 77. Grunenthal Company Detail
Table 78. Grunenthal Business Overview
Table 79. Grunenthal Prescription Migraine Medication Product
Table 80. Grunenthal Revenue in Prescription Migraine Medication Business (2018-2024) & (US$ Million)
Table 81. Grunenthal Recent Development
Table 82. Eli Lilly Company Detail
Table 83. Eli Lilly Business Overview
Table 84. Eli Lilly Prescription Migraine Medication Product
Table 85. Eli Lilly Revenue in Prescription Migraine Medication Business (2018-2024) & (US$ Million)
Table 86. Eli Lilly Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prescription Migraine Medication Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Prescription Migraine Medication Market Share by Type: 2022 VS 2029
Figure 3. Sumatriptan Features
Figure 4. Rizatriptan Features
Figure 5. Others Features
Figure 6. Global Prescription Migraine Medication Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Prescription Migraine Medication Market Share by Application: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Drug Store Case Studies
Figure 11. Prescription Migraine Medication Report Years Considered
Figure 12. Global Prescription Migraine Medication Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Prescription Migraine Medication Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Prescription Migraine Medication Market Share by Region: 2022 VS 2029
Figure 15. Global Prescription Migraine Medication Market Share by Players in 2022
Figure 16. Global Top Prescription Migraine Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Migraine Medication as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Prescription Migraine Medication Revenue in 2022
Figure 18. North America Prescription Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Prescription Migraine Medication Market Share by Country (2018-2029)
Figure 20. United States Prescription Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Prescription Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Prescription Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Prescription Migraine Medication Market Share by Country (2018-2029)
Figure 24. Germany Prescription Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Prescription Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Prescription Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Prescription Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Prescription Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Prescription Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Prescription Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Prescription Migraine Medication Market Share by Region (2018-2029)
Figure 32. China Prescription Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Prescription Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Prescription Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Prescription Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Prescription Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Prescription Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Prescription Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Prescription Migraine Medication Market Share by Country (2018-2029)
Figure 40. Mexico Prescription Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Prescription Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Prescription Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Prescription Migraine Medication Market Share by Country (2018-2029)
Figure 44. Turkey Prescription Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Prescription Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. GSK Revenue Growth Rate in Prescription Migraine Medication Business (2018-2024)
Figure 47. Teva Revenue Growth Rate in Prescription Migraine Medication Business (2018-2024)
Figure 48. Pfizer Revenue Growth Rate in Prescription Migraine Medication Business (2018-2024)
Figure 49. Amgen Revenue Growth Rate in Prescription Migraine Medication Business (2018-2024)
Figure 50. Viatris Revenue Growth Rate in Prescription Migraine Medication Business (2018-2024)
Figure 51. Allergan Revenue Growth Rate in Prescription Migraine Medication Business (2018-2024)
Figure 52. Grunenthal Revenue Growth Rate in Prescription Migraine Medication Business (2018-2024)
Figure 53. Eli Lilly Revenue Growth Rate in Prescription Migraine Medication Business (2018-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed